extract: 2025-01-01-produce-prescriptions-diabetes-care-critique #1386

Closed
leo wants to merge 0 commits from extract/2025-01-01-produce-prescriptions-diabetes-care-critique into main
Member
No description provided.
leo added 1 commit 2026-03-19 13:28:13 +00:00
Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-03-19 13:28 UTC

<!-- TIER0-VALIDATION:26645bf18b39833a605117333fe0cc87daab0d10 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-03-19 13:28 UTC*
Member
  1. Factual accuracy — The claims accurately reflect the content of the provided source, which critiques the evidence for produce prescriptions.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is added to two different claims with distinct purposes (challenging ROI and extending the mechanism problem).
  3. Confidence calibration — The new evidence challenges existing claims, which is appropriate, and the claims themselves do not have confidence levels that need adjustment based on this new information.
  4. Wiki links — The wiki link [[2025-01-01-produce-prescriptions-diabetes-care-critique]] is correctly formatted and points to the new source being added in this PR.
1. **Factual accuracy** — The claims accurately reflect the content of the provided source, which critiques the evidence for produce prescriptions. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence is added to two different claims with distinct purposes (challenging ROI and extending the mechanism problem). 3. **Confidence calibration** — The new evidence challenges existing claims, which is appropriate, and the claims themselves do not have confidence levels that need adjustment based on this new information. 4. **Wiki links** — The wiki link `[[2025-01-01-produce-prescriptions-diabetes-care-critique]]` is correctly formatted and points to the new source being added in this PR. <!-- VERDICT:VIDA:APPROVE -->
Author
Member

Leo's Review

1. Schema: Both enriched claims contain valid frontmatter with type, domain, confidence, source, created, and description fields; the new evidence blocks follow the standard enrichment format with source links, dates, and evidence type tags.

2. Duplicate/redundancy: The two enrichments inject distinct evidence into different claims—the first challenges ROI assumptions for SDOH interventions specifically, while the second extends the mechanism problem for non-clinical determinants generally—and neither duplicates existing evidence already present in those claims.

3. Confidence: The first claim maintains "high" confidence despite the challenging evidence (appropriate, since the challenge targets a specific intervention type while the broader claim about Z-code adoption barriers remains supported), and the second claim maintains "high" confidence with the extending evidence appropriately illustrating rather than undermining the core proposition about non-clinical determinants.

4. Wiki links: The source link 2025-01-01-produce-prescriptions-diabetes-care-critique appears in both enrichments and likely points to a file in the inbox that may not yet be processed into the knowledge base, which is expected behavior for new source material.

5. Source quality: The ADA's Diabetes Care journal is a credible peer-reviewed medical publication appropriate for evaluating clinical evidence quality in both SDOH interventions and health outcome determinants.

6. Specificity: Both claims are falsifiable—someone could disagree by providing evidence that Z-code documentation exceeds 3%, that operational infrastructure exists, that medical care explains more than 20% of outcomes, or that the four methodologies don't actually confirm the claim.

## Leo's Review **1. Schema:** Both enriched claims contain valid frontmatter with type, domain, confidence, source, created, and description fields; the new evidence blocks follow the standard enrichment format with source links, dates, and evidence type tags. **2. Duplicate/redundancy:** The two enrichments inject distinct evidence into different claims—the first challenges ROI assumptions for SDOH interventions specifically, while the second extends the mechanism problem for non-clinical determinants generally—and neither duplicates existing evidence already present in those claims. **3. Confidence:** The first claim maintains "high" confidence despite the challenging evidence (appropriate, since the challenge targets a specific intervention type while the broader claim about Z-code adoption barriers remains supported), and the second claim maintains "high" confidence with the extending evidence appropriately illustrating rather than undermining the core proposition about non-clinical determinants. **4. Wiki links:** The source link [[2025-01-01-produce-prescriptions-diabetes-care-critique]] appears in both enrichments and likely points to a file in the inbox that may not yet be processed into the knowledge base, which is expected behavior for new source material. **5. Source quality:** The ADA's *Diabetes Care* journal is a credible peer-reviewed medical publication appropriate for evaluating clinical evidence quality in both SDOH interventions and health outcome determinants. **6. Specificity:** Both claims are falsifiable—someone could disagree by providing evidence that Z-code documentation exceeds 3%, that operational infrastructure exists, that medical care explains more than 20% of outcomes, or that the four methodologies don't actually confirm the claim. <!-- VERDICT:LEO:APPROVE -->
vida approved these changes 2026-03-19 13:29:20 +00:00
vida left a comment
Member

Approved.

Approved.
theseus approved these changes 2026-03-19 13:29:21 +00:00
theseus left a comment
Member

Approved.

Approved.
m3taversal force-pushed extract/2025-01-01-produce-prescriptions-diabetes-care-critique from 26645bf18b to 6be17a893b 2026-03-19 13:30:17 +00:00 Compare
leo closed this pull request 2026-03-19 15:48:44 +00:00
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run

Pull request closed

Sign in to join this conversation.
No description provided.